Old Politics, New Disease Clash in China

©1999 Myrna WatanabeMeeting attendees at the Great Wall A 30-yuan (about $3.60) card will admit you to the Badaling entrance of China's Great Wall. But you don't just swipe it through a slot as you might at a gasoline pump or cash machine. You place the card in the slot of the magnetic strip reader and a real, live attendant will retrieve the card and hand it back to you. This is the conundrum that is China: It is using cutting-edge technologies but clinging to the old ways. This, according

Written byMyrna Watanabe
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

©1999 Myrna Watanabe

Meeting attendees at the Great Wall
A 30-yuan (about $3.60) card will admit you to the Badaling entrance of China's Great Wall. But you don't just swipe it through a slot as you might at a gasoline pump or cash machine. You place the card in the slot of the magnetic strip reader and a real, live attendant will retrieve the card and hand it back to you.

This is the conundrum that is China: It is using cutting-edge technologies but clinging to the old ways. This, according to some, is the way China is facing its growing HIV epidemic, now estimated to have infected 400,000 people in this country of 1.3 billion.

The bumpy interface between the old and new Chinas was evident--even in mild ways--at China's first International AIDS Vaccine Workshop, held in Beijing with a subsequent field trip to Yunnan Province, Nov. 18-23, 1999. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies